Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Letter |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/45268 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Mahidol University |
| id |
th-mahidol.45268 |
|---|---|
| record_format |
dspace |
| spelling |
th-mahidol.452682019-08-28T13:27:18Z Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study Ali T. Taher Zeynep Karakas Elena Cassinerio Noppadol Siritanaratkul Antonis Kattamis Aurelio Maggio Stefano Rivella Norbert Hollaender Bruyere Mahuzier Brian Gadbaw Yesim Aydinok American University of Beirut Medical Center Università degli Studi di Milano The Children's Hospital of Philadelphia National and Kapodistrian University of Athens Novartis Pharma S.A.S. Istanbul Üniversitesi Tıp Fakültesi Faculty of Medicine, Siriraj Hospital, Mahidol University Novartis International AG Ege University Medical School Novartis Pharmaceuticals Corporation UOSD MICI-A.O. Ospedali Riuniti “Villa Sofia-Cervello” Palermo Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine 2019-08-23T10:38:19Z 2019-08-23T10:38:19Z 2018-01-11 Letter Blood. Vol.131, No.2 (2018), 263-265 10.1182/blood-2017-06-790121 15280020 00064971 2-s2.0-85040441699 https://repository.li.mahidol.ac.th/handle/123456789/45268 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85040441699&origin=inward |
| institution |
Mahidol University |
| building |
Mahidol University Library |
| continent |
Asia |
| country |
Thailand Thailand |
| content_provider |
Mahidol University Library |
| collection |
Mahidol University Institutional Repository |
| topic |
Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine |
| spellingShingle |
Biochemistry, Genetics and Molecular Biology Immunology and Microbiology Medicine Ali T. Taher Zeynep Karakas Elena Cassinerio Noppadol Siritanaratkul Antonis Kattamis Aurelio Maggio Stefano Rivella Norbert Hollaender Bruyere Mahuzier Brian Gadbaw Yesim Aydinok Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| author2 |
American University of Beirut Medical Center |
| author_facet |
American University of Beirut Medical Center Ali T. Taher Zeynep Karakas Elena Cassinerio Noppadol Siritanaratkul Antonis Kattamis Aurelio Maggio Stefano Rivella Norbert Hollaender Bruyere Mahuzier Brian Gadbaw Yesim Aydinok |
| format |
Letter |
| author |
Ali T. Taher Zeynep Karakas Elena Cassinerio Noppadol Siritanaratkul Antonis Kattamis Aurelio Maggio Stefano Rivella Norbert Hollaender Bruyere Mahuzier Brian Gadbaw Yesim Aydinok |
| author_sort |
Ali T. Taher |
| title |
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| title_short |
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| title_full |
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| title_fullStr |
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| title_full_unstemmed |
Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a study |
| title_sort |
efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study |
| publishDate |
2019 |
| url |
https://repository.li.mahidol.ac.th/handle/123456789/45268 |
| _version_ |
1763488586943954944 |